Featured Sessions
Thursday, February 24, 2022
Coding, Compliance, and Documentation in Wound Care
8:00 am — 1:00 pm ET
Facilitated by Jeffrey D. Lehrman, DPM, FASPS, MAPWCA, CPC; Moira Sykstus. MHA, CPCO, RRT, CHT
Learning Objectives:
At the competition of this activity, participants should be able to:
- List the four CPT® codes used for ulcer debridement
- Differentiate between an ulcer and a wound
- Define a significant and separately identifiable evaluation and management
friday, February 25, 2022
Nutrition and Wound Healing: The Recipe for Success
4:15 PM – 5:00 PM EST
Moderated/Facilitated by Nancy Collins, PhD, RDN, LD, NWCC, FAND
Matthew M. M Melin, MD, FACS, RPVI, FACCWS & Frank Aviles, PT, CWS, FACCWS, CLT-LANA, ALM, AWCC, DAPWCA, MLD/CDT Instr
friday, February 25, 2022
Diagnosing & Treating Chronic Venous Insufficiency
2:45 PM – 3:45 PM EST
Chronic Venous Insufficiency (CVI) affects millions of people in the United States. Late stage CVI (CEAP stages 3-6) is associated with lymphatic dysfunction that may be worsened by a genetic component. Unrecognized and treated improperly, the protein deposition and significant chronic interstitial fluid pressure can compromise micro arterial perfusion (rarefaction), resulting in chronic subcritical dermal ischemia and development of skin pathologic changes and ulceration. This program will emphasize how to diagnose and treat venous insufficiency and associated lymphedema of venous etiology (phlebolymphedema).
Learning Objectives:
- At the competition of this activity, participants should be able to:
- Describe the pathophysiology of Chronic Venous Insuficiency (CVI)
- Describe lymphatic and glycocalyx component of CVI
- Describe diagnostic evaluation and therapeutic options for CVI
Saturday, February 26
Management of Lower Extremity Edema
2:30 PM – 3:30 PM EST
Technological diagnostic advances has shed light on the nanostructure and function of the endothelial luminal gel lining, now recognized as the glycocalyx. The functional purpose of the glycocalyx is mechanacotransduction of vessel luminal shear resulting in Endothelial cell production of various cytokines and nitric oxide (NO), a Permeability layer, to quench Inflammation, and to mitigate against Coagulation development (glycocalyx functions are EPIC). Glycocalyx “shedding,” caused by hyperglycemia, hypertension, hyperlipidemia, trauma, sepsis, tobacco, chemotherapy, may contribute to interstial edema development due to hyperpermeability of the microvasculature, which overwhelms the lymphatic capacity to transport fluid to the central lymphatic vessels and central venous system. An overwhelmed lymphatic system results in an inability to control interstitial edema and a resulting compromise in the local /regional immune function. Interstial edema may be the result of various etiologies (venous thromboses, trauma, medications, ischemia reperfusion). An understanding of the possible causes provide for improved recognition and treatment. This program will emphasize diagnosis and management of lower extremity edema and lymphedema.
Learning Objectives:
- At the competition of this activity, participants should be able to:
- Describe differential diagnosis of lower extremity causes
- Describe evaluation and management priciples of lower extremity edema including pharmacologic options
- Describe interstitial edema, lymphatic dysfunction and glycocalyx components of lower extremity edema